The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,5R)1-[4-(2-fluoro-5-chlorobenzyloxy)-benzenesulfonyl]-5-hydroxy-3,3-dimethylpiperidine-2-carboxylicacid hydroxyamide ID: ALA3909799
PubChem CID: 58619815
Max Phase: Preclinical
Molecular Formula: C21H24ClFN2O6S
Molecular Weight: 486.95
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)C[C@@H](O)CN(S(=O)(=O)c2ccc(OCc3cc(Cl)ccc3F)cc2)[C@H]1C(=O)NO
Standard InChI: InChI=1S/C21H24ClFN2O6S/c1-21(2)10-15(26)11-25(19(21)20(27)24-28)32(29,30)17-6-4-16(5-7-17)31-12-13-9-14(22)3-8-18(13)23/h3-9,15,19,26,28H,10-12H2,1-2H3,(H,24,27)/t15-,19+/m1/s1
Standard InChI Key: XOODFFUDKRERSH-BEFAXECRSA-N
Molfile:
RDKit 2D
32 34 0 0 0 0 0 0 0 0999 V2000
5.5883 -7.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2982 -6.9998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5929 -6.5872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1731 -5.1219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8830 -5.5305 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.8819 -4.7114 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5003 -6.2512 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6836 -6.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7322 -7.6939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5489 -7.6658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9330 -6.9445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2509 -5.5860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6350 -4.8647 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4342 -5.6141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0016 -4.9208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7014 -5.5314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1100 -4.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9271 -4.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3357 -5.5314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9271 -6.2391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1100 -6.2391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1529 -5.5314 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5615 -6.2391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3787 -6.2391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7873 -5.5314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6045 -5.5314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0131 -6.2391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6045 -6.9468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7873 -6.9468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3787 -4.8237 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.0131 -7.6545 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.9815 -8.3591 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
5 4 2 0
6 5 2 0
7 8 1 0
8 2 1 0
2 9 1 0
9 10 1 0
10 11 1 0
7 11 1 0
12 13 2 0
14 15 1 0
12 14 1 0
8 12 1 6
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
5 16 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
24 29 2 0
22 23 1 0
19 22 1 0
7 5 1 0
25 30 1 0
28 31 1 0
10 32 1 6
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 486.95Molecular Weight (Monoisotopic): 486.1028AlogP: 2.71#Rotatable Bonds: 6Polar Surface Area: 116.17Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.71CX Basic pKa: ┄CX LogP: 2.74CX LogD: 2.72Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.43Np Likeness Score: -0.99
References 1. (2001) Selective inhibitors of aggrecanase in osteoarthritis treatment,